The Syrian hamster (Mesocricetus auratus) possesses a variety of unique features which make them desirable research models. Despite these features, experimental use of the hamster has declined over the past 20--30 years. The current chapter will focus on research and literature describing the experimental use of the hamster with a particular emphasis on research done since the previous edition of this text (1987--present).

Introduction {#s0010}
============

The Syrian hamster (*Mesocricetus auratus*) is a widely used experimental animal model. A recent fiscal-year report from the USDA indicates that 172 498 hamsters were used in 2007. Although the hamster still makes a significant contribution to research and teaching, the number of hamsters utilized currently is well below their peak usage of over 500 000 achieved during the 1980s ([@bib101]). Much of this decline is likely attributable to the availability and widespread use of genetically engineered mice. Despite this decline, the hamster still provides key data for a variety of research areas. As such, this chapter will focus primarily on the most current research uses of the hamster. More classical uses will be covered only as they pertain to these current uses.

Hamsters possess unique anatomical and physiological features which make them desirable research models. Unlike other commonly used laboratory rodents, hamsters possess a cheek pouch which can be easily everted and examined in situ at both the gross and microscopic level ([@bib101]). The hamster's relative size also allows for better visualization of certain biological systems including the respiratory and reproductive systems when compared to the mouse ([@bib167]). Additionally, hamsters are relatively free of pathogens yet they are naturally susceptible to a wide range of experimental pathogens ([@bib101]). Further, laboratory hamsters develop a variety of inherited diseases which display similarities to human conditions. Hamsters possessing some of these inherited traits are commercially available (Biobreeders Inc. Watertown, MA; [Table 34.1](#t0010){ref-type="table"} ). In addition to these benefits, hamsters are susceptible to a variety of carcinogens and develop tumors that other research animals less commonly develop. Furthermore, hamsters are susceptible to the induction of a variety of metabolic disorders through the use of dietary manipulations. Finally, the antagonistic nature of hamsters is utilized to study the effect of treatment on male aggressive and defensive behaviors.Table 34.1Inbred and Spontaneous Mutant Hamsters Currently Available and Their Uses in ResearchNameResearch UseBio 1.5Carcinogenicity and dental cariesBio 14.6Cardiomyopathy and muscular dystrophyBio 15.16Carcinogenicity studiesBio F1BDiabetes and atherosclerosisBio HTHypertensionBio To-2Cardiomyopathy and muscular dystrophy

Cancer Research {#s0015}
===============

Syrian hamsters display several unique characteristics that make them desired models for carcinogenesis studies. Specifically, they develop tumor types that other models, particularly the mouse, are less apt to develop. Further, they can be reliably infected with oncogenic and oncolytic viruses. This section details the most commonly used hamster models of cancer and carcinogenesis and highlights the key findings discovered in these models.

Pancreatic Adenocarcinoma {#s0020}
-------------------------

Pancreatic tumors of non-endocrine origin are particularly aggressive tumors with a poor prognosis in humans ([@bib279]). The most common anatomic form of this tumor is ductular adenocarcinoma. The Syrian hamster is used extensively to study this tumor. Most commonly, the tumors are induced by the administration of nitrosamines (particularly *N*-nitrosobis amine) as a single subcutaneous injection. The resulting tumor is both morphologically and biologically similar to human pancreatic ductal adenocarcinoma ([@bib279]). One of the limitations of this model is the prolonged time-course for tumor induction (as long as 51 weeks). This time-course can be expedited by giving multiple nitrosamine injections ([@bib138]). Additional limiting factors of the model are the incomplete penetrance of tumor formation even with multiple injections and the low rate of tumor metastasis ([@bib138], [@bib185]). Environmental factors, including a choline-deficient diet, given in combination with nitrosamines produce tumors more rapidly and with a greater prevalence in both male and female hamsters ([@bib184], [@bib182], [@bib183]).

Current studies utilizing the carcinogen injection model focus on treatment and reduction of tumor development. Specifically, chemicals and biologics with the potential to prevent cancer can be given synchronously or shortly after carcinogen administration, and effectiveness in cancer reduction (both tumor size and prevalence) can be assessed phenotypically at specified time points. Utilizing this general scheme several potential anti-cancer compounds were identified, including dimethylamino-parthenolide, celecoxib, iNOS inhibitors, and melatonin ([@bib231], [@bib268], [@bib305]). Alternatively, studies can be carried out after induction to determine the efficacy of tumor treatment and metastasis prevention. This approach recently demonstrated that somatostatin analogs are able to decrease metastasis of pancreatic cancers ([@bib131]).

More recently, a transplantable cell line, PGHAM-1, was isolated from the pancreata of hamsters with induced pancreatic cancer ([@bib87]). A variety of other biological behaviors can be induced with this transplantable model. Specifically, if the cell line is injected into the pancreas, hamsters develop pancreatic cancer which metastasizes to the liver whereas splenic injection induces direct metastasis to the liver, and intraperitoneal injection induces dissemination to the entire peritoneal cavity ([@bib279]). Therefore, this model can be used to study the primary disease, metastasis, and dissemination in a rapid fashion. An additional benefit of the transplant model is that it is characterized molecularly and is known to contain mutations of *k-ras*, *Vegf*, and matrix metalloproteinases similar to human pancreatic adenocarcinoma cells ([@bib170]).

Respiratory Tract Tumors {#s0025}
------------------------

### Primary Lung Tumors {#s0030}

The two predominant types of lung cancer in humans are small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) ([@bib137], [@bib211]). NSCLC are lung tumors which originate from diverse cell types but behave and are treated in similar fashions. In contrast, SCLC originates primarily from neuroendocrine cells of the respiratory tract ([@bib150]). Both tumor types are associated with tobacco smoking in humans.

In hamsters, lung tumors are induced by carcinogen treatment and typically result in NSCLC. One method to induce lung tumors is to inject the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) subcutaneously ([@bib264]). Multiple injections must be given over a prolonged (6 months or longer) time course. Modifications to this induction protocol include the use of hyperoxia in conjunction with the carcinogen treatment ([@bib196]). Presumably, the addition of hyperoxia increases the potential for free-radical damage to DNA of the lung tissue. The NNK model displays molecular characteristics of human NSCLC including mutations in the *k-ras* gene ([@bib195], [@bib196]). A thorough immunohistochemical characterization of both the chemical model and the chemical plus hyperoxia model indicates that both experimental paradigms induce similar lung lesions that display strong similarity to human NSCLC at the protein level ([@bib264]).

### Upper Airway Tumors {#s0035}

Upper airway tumors occur in the larynx, trachea, or pharynx. The primary risk factors for development of these tumors are smoking and chronic alcohol consumption; however, other environmental and genetic factors may contribute to the disease ([@bib256]).

The hamster is susceptible to tumors of the upper airways. These tumors are induced by inhalation or topical application of carcinogens with or without the addition of co-carcinogenic stimuli ([@bib77], [@bib111], [@bib187], [@bib188]). A reported limitation of topical carcinogen application models is the lack of reproducibility among different labs ([@bib77]). It is unclear why various labs are unable to faithfully reproduce the cancer phenotype using the same protocols; however, one possibility is that because the hamsters came from different sources, they may be genetically different. To overcome this limitation, a recent publication describes combining the administration of N-methylnitrosourea (MNU) with direct wounding of the tissue ([@bib77]). The experimental design includes two tracheal wounding procedures done under general anesthesia. The trachea is gently abraded using a curette and this abrasion is coupled with six applications of MNU using a gavage needle. The induction of the wound induces epithelial proliferation which acts epigenetically in conjuction with the genotoxic mutagen to promote carcinogenesis. A benefit of this model is the coinduction of esophageal tumors which mimics the epidemiological linkage of these two tumor types in human smokers ([@bib291]). The model can be altered to incorporate preventative and post-induction treatments. Utilizing this paradigm, difluoromethylornithine (DFMO; a mitosis inhibitor) and 5-fluorouracil (5-FU; a DNA replication inhibitor) treatments were both found to reduce the prevalence of tumor formation in hamsters ([@bib291]).

Oral Carcinogenesis {#s0040}
-------------------

Oral squamous cell carcinoma (OSCC) is a common cancer of humans and generally carries a poor prognosis ([@bib281], [@bib282]). Primary risk factors for the development of OSCC include tobacco and alcohol use, but other genetic and environmental factors contribute as well ([@bib293]). The hamster cheek-pouch carcinogenesis model is one of the most accepted animal models to study oral tumor formation and progression ([@bib280], [@bib281], [@bib282]). Carcinogens, most notably 7,12-dimethylbenz(a)anthracene (DMBA), administered by repeated topical application to the buccal pouch, induces carcinomas rapidly (\~14 weeks) ([@bib282]). The DMBA administration technique is simple and involves anesthetizing the hamsters and brushing the desired carcinogen onto the buccal surface of the cheek pouch. Importantly, oncogenesis can be assayed in vivo or the transformed cells can be grown ex vivo ([@bib297]).

Tumor formation and progression in the hamster cheek pouch occurs in a predictable, reproducible step-wise fashion. First, hyperkeratosis develops followed rapidly by hyperplasia and dysplasia. Finally, these lesions progress to invasive carcinomas ([@bib282]). Cellular and molecular alterations that occur during these predictable stages of tumorigenesis are extensively characterized ([@bib280], [@bib282]). The cellular and molecular alterations in the hamster display many similarities to human OSCC. Early in the disease, tyrosine kinase receptors are highly expressed in hamsters similar to the increase of the ErbB2 tyrosine kinase noted in humans ([@bib292]). Additionally, the oncogenes p53 and c-myc are highly expressed early in hamster tumorigenesis and there is a loss of expression of the p16 tumor suppressor gene during the early dysplastic stage ([@bib200], [@bib280]). More recently, the microRNA expression profile of the DMBA-treated hamster cheek pouch has been analyzed and compared to normal cells. Treated cells display a unique microRNA profile distinct from normal tissue ([@bib306]). These data imply that microRNA may play a role in the formation and progression of hamster check pouch tumors. The similarities of these new data to the human disease are not yet known.

A key advantage of the hamster cheek pouch carcinogenesis model is the predictable nature of tumor progression. Because of this predictability, the hamster model is also utilized to analyze various treatments and preventatives which may be given either concurrently with induction or at specified points during tumorigenesis ([@bib242], [@bib251]). Since the hamster cheek pouch undergoes a predictable pathway of induced oncogenesis, these studies can be accurately timed to the appropriate tumor stage or pre-cancerous lesion. A more recently described advantage of the hamster model is the isolation of buccal pouch stem cells, which can be studied in vitro and may provide data on novel treatments ([@bib116]).

SV40 Tumor Induction {#s0045}
--------------------

Simian vacuolating virus 40 (SV40) is a polyomavirus naturally occurring in macaques that was introduced into humans via contaminated polio vaccines ([@bib203], [@bib223]). The role of SV40 in human cancers has a long and controversial history. Large epidemiological studies tracking infected humans indicate no link between the agent and cancer ([@bib223]). Proponents of the link between SV40 and cancer state that the true prevalence of SV40 in the human population is not known, and therefore, an accurate epidemiological assessment cannot be made ([@bib203]). Detailing the controversies surrounding the role of the SV40 virus in human tumors is beyond the scope of the current chapter. However, the hamster figures prominently into the data detailing the oncogenic potential of SV40.

Hamsters injected with SV40 develop a variety of different tumors depending on the route of inoculation and the age of hamsters at the time of inoculation. Tumor formation is highest in newborn hamsters and decreases progressively with age ([@bib47]). Local fibrosarcomas develop with subcutaneous injection of virus, even when given at a low dose in newborn hamsters. In contrast, adults develop fibrosarcomas only when given a high dose of virus ([@bib10], [@bib47]). Intravenous inoculation of young hamsters produces a variety of tumors including leukemia, lymphoma, and a variety of sarcomas ([@bib47], [@bib67]). Finally, mesotheliomas develop when hamsters are injected with virus into the heart, peritoneum, or pericardium ([@bib47]). SV40 viral infection can therefore be utilized to analyze a variety of tumor types using the hamster model.

Recent studies utilizing the hamster lend further evidence to support the hypothesis that SV40 may play a role in human carcinogenesis. Hamsters that are infected with a non-oncogenic SV40 virus strain or a low dose of asbestos, fail to develop tumors. In contrast, when sub-oncogenic doses of the two agents are given together a large percentage of hamsters (90%) develop tumors ([@bib143]). Additionally, these results are reproducible in in vitro cell-culture systems. These data imply that, at least in the hamster, SV40 and asbestos can act as co-carcinogens.

The role of SV40 in human cancers remains highly controversial. However, the hamster model provides an excellent way to prospectively test these hypotheses. Even if SV40 plays no role in human tumorigenesis, much can still be learned from the hamster model regarding how viral agents transform mammalian cells. For example, a recent study demonstrates that differences in the SV40 regulatory region lead to differences in tumor induction in the hamster model ([@bib258]). These new data provide evidence that various strains of virus possess pro-oncogenic factors and these data argue that epidemiological studies in humans should account not merely for the presence or absence of SV40, but rather for the type of SV40 present.

Estrogen-Dependent Renal Tumors {#s0050}
-------------------------------

Exogenous estrogen therapy in post-menopausal women decreases the risk of developing both osteoporosis and coronary artery disease; however, it also increases the risk for development of breast cancer and endometrial adenocarcinoma in this population ([@bib236], [@bib259]). The benefits and limitations of the use of estrogen therapy in postmenopausal women remains an active area of research and debate. Animal models of estrogen-induced tumorigenesis provide valuable mechanistic data to optimize estrogen therapy.

The Syrian hamster is a valuable model to study the effects of exogenous estrogenic compounds on tumor development. The administration of estrogens induces renal tumors in 100% of male hamsters in a predictable fashion ([@bib155], [@bib158]). Most commonly, estrogens are administered to hamsters in the form of slow-release subcutaneous implants which maintain constant levels in the blood ([@bib63]). In addition to in vivo studies utilizing the estrogen injection or implantation hamster model, HKT-1097 cell-lines generated from this model can be studied in vitro ([@bib148]).

A wealth of mechanistic data on the tumorigenic potential of estrogenic compounds has been generated utilizing the hamster model. Specifically, administration of a variety of natural and synthetic estrogenic compounds demonstrates that tumorigenesis occurs with some estrogenic compounds but not others ([@bib158], [@bib159], [@bib160], [@bib161]). These data led to the hypothesis that tumorigenic estrogens mediate carcinogenicity, at least in part, through their metabolic breakdown products ([@bib158]). In particular, estrogen is broken down to 4-hydroxyestrogen, a catecholestrogen, in the hamster kidney ([@bib71], [@bib158]). This intermediate can be further broken down into quinones which cause DNA damage by forming DNA adducts. This pathway, initially characterized in the hamster, was later identified in women with breast cancer. Specifically, the "normal" breast tissue of women with breast cancer displays higher levels of quinones when compared to unaffected controls ([@bib156], [@bib220]). The estrogen receptor may be actively involved in tumor formation by shuttling quinone directly to nuclear DNA ([@bib32]).

Aside from the ability of quinones to directly damage DNA, quinine production results in the formation of reactive oxygen which can also cause DNA damage ([@bib156], [@bib158]). Since the breakdown products of estrogen can damage DNA (mutation), and estrogen itself can promote cell growth (proliferation), all of the necessary components of carcinogenesis are present in the estrogen-treated hamster kidney ([@bib158]). The administration of some estrogenic compounds does not damage DNA because toxic metabolic byproducts are not generated ([@bib26]). Cancer induction with these compounds can be rescued by inducing oxidative stress while administering these normally non-oncogenic estrogens. This finding highlights the need for both the proliferative and the DNA-damaging aspects of estrogen to produce tumors. The hamster model may facilitate development of novel, non-DNA-damaging, estrogens which could provide the benefits of estrogenic therapy without the increased risk of cancer.

Oncolytic Viruses {#s0055}
-----------------

The use of oncolytic adenoviruses holds promise as a future cancer treatment in humans. These adenoviruses kill tumor cells as part of their normal lytic replication cycle ([@bib273]). The prospective in vivo study of these viruses is hampered by the lack of animal models that permit the replication of human adenoviruses ([@bib108], [@bib273]). However, the hamster can be infected with human adenoviruses via intranansal instillation ([@bib108]). In addition, permissive hamster cancer cell lines are available for assessing tumor suppression ([@bib33], [@bib273]). Notably, the Syrian hamster pancreatic carcinoma cell line (SHPC6) is highly permissive for human adenovirus replication ([@bib255]).

Thomas and colleagues recently developed a step-wise, reproducible hamster model to study the efficacy of adenoviral vectors in tumor therapy ([@bib274]). The investigators injected immortalized tumor cells into the flanks of hamsters. After tumors developed, hamsters were inoculated with adenovirus into the respiratory tract. Tumor reduction at both the primary site, and the site of metastasis, was then analyzed. The investigators found that adenovirus inhibits primary tumor growth and metastasis and may promote survival (depending on tumor type injected). The virus is capable of replicating in the liver, lungs, and tumor tissues of the hamster following instillation and distribution in the blood ([@bib274]). This experimental paradigm can be expanded to examine the treatment of a variety of tumors in the hamster and potential toxicities associated with the use of these viruses ([@bib66], [@bib157]). A further modification of this method is immunosuppression of hamsters with cyclophosphamide which allows for sustained adenoviral replication and oncolysis ([@bib275]). The hamster provides a valuable experimental model to evaluate the potential benefits, limitations, and strategies of this novel treatment modality.

Metabolic Diseases {#s0060}
==================

Metabolic diseases are an area of great biomedical concern. Although all these diseases may occur independently of one another, they often present with a variety of overlapping clinical signs. Like humans, the hamster is highly susceptible to metabolic diseases and there are similar overlaps in the signs that they develop ([@bib89], [@bib94], [@bib146], [@bib147]). Therefore, the hamster is an excellent animal model to study metabolic diseases of humans.

Cholesterol Gallstones {#s0065}
----------------------

Cholesterol cholelithiasis is a significant health problem worldwide. The prevalence of this condition is three times higher in women than in men and increases regularly with age ([@bib41]). The Syrian hamster is commonly used as a model for this condition which can be induced by excess dietary cholesterol ([@bib50], [@bib278]) or sucrose ([@bib129]). The metabolism of cholesterol in the hamster is similar to humans ([@bib130]). The nature and composition of hydrophobic bile salts and the ratio of taurine- and glycine-conjugated bile salts are similar in hamsters and humans ([Figure 34.1](#f0010){ref-type="fig"} ) ([@bib52], [@bib102], [@bib248]). In earlier studies, gallstones were induced in Syrian hamsters by feeding a fat-free glucose-rich diet ([@bib58]). Diet models have evolved to include elevated levels of butterfat ([@bib51], [@bib106], [@bib110]). In hamsters, the butterfat-diet induces a high cholesterol/phospholipid ratio in bile which promotes cholesterol cholelithiasis. In contrast, diets rich in safflower oil induce phospholipid secretion and reduce the lithogenicity of bile, thereby inhibiting cholesterol gallstones ([@bib193]).Figure 34.1Distribution of different bile acids in vesicular bile of hamsters (left) and humans (right). The ratio of glyco- and tauro-conjugated bile acids is very similar in both species. C, cholic; CDC, chenodeoxycholic; DC, deoxycholic; LC, lithocholic acid.Modified from Combettes-Souverain et al. 2002, with permission from Elsevier Limited.

The Syrian hamster displays significant gender differences in the basal rate of hepatic sterol synthesis which is several-fold higher in females fed a regular chow diet as compared to age-matched males on the same diet ([@bib254]). In contrast to humans, female hamsters are less susceptible to gallstones because they maintain more favorable biliary lipid and bile acid profiles (predominantly glycocholate) characterized by lower molar percentages of cholesterol and chenodeoxycholate ([@bib20], [@bib278]). Dietary administration of androgens to female hamsters on a lithogenic diet (0.3% cholesterol) induces cholesterol gallstones at a comparable rate to induction in males fed a similar diet. In these androgen-treated, cholesterol-fed female hamsters, chenodeoxycholate increases while cholate decreases ([@bib19]). Furthermore, castrated male hamsters on the lithogenic diet do not form cholesterol gallstones, and maintain a higher ratio of biliary cholate to chenodeoxycholate as compared to uncastrated males ([@bib194]).

Male LPN hamsters (bred at Laboratoire de Physiologie et de la Nutrition, France) are highly susceptible to cholesterol gallstones (\~70%) induced by a low-fat high-sucrose diet, whereas commercial Janvier (JAN) hamsters on a similar diet do not develop gallstones ([@bib31], [@bib52], [@bib82]). In LPN hamsters, the sucrose-rich lithogenic diet causes an increase in biliary cholesterol and phospholipid. A cholesterol-enriched diet results in hypercholesterolemia, increased liver cholesterol, and reduced cholesterologenesis along with expression of the LDL receptor in both LPN and JAN hamsters ([@bib253]). In both strains, the cholesterol-enriched diet increases the cholesterol content in both the LDL and HDL fractions of sera ([@bib253], [@bib298]). Further, excess dietary cholesterol leads to a reduction of CYP7A (the rate-limiting enzyme in the classical pathway of cholesterol breakdown to bile salts) activity and transcription in both LPN and JAN hamsters ([@bib253]). There is a concurrent stimulation of sterol 27-hydroxylase (CYP27) and oxysterol 7α-hydroxylase (CYP7B), enzymes involved in the alternative bile-salt pathway of cholesterol conversion to bile salts in both LPN and JAN hamsters. Compared with LPN hamsters, hypercholesterolemia in JAN hamsters is associated with hepatomegaly and fatty liver but only modest hypertriglyceridemia. Interestingly, after cholesterol feeding for 5 weeks, neither LPN nor JAN hamsters develop cholesterol gallstones, perhaps because of the upregulation of the alternative pathway of bile-salt synthesis ([@bib253]).

Differences in gallstone formation also exist between commercially available hamsters. Charles River Laboratory hamsters display the highest cholesterol saturation of bile on low-cholesterol diets and display a correspondingly high prevalence of stones (64%) when challenged with a high-cholesterol diet ([@bib277]). Biobreeder F1 hamsters also commonly form gallstones (58%) when challenged with cholesterol-enriched diets. In contrast, Harlan Sprague-Dawley hamsters display a low prevalence (23%) of gallstones when fed the same diet ([@bib277]). These findings highlight the role of genetics in both hamsters and humans in this complex polygenic disease. One drawback of this study is that the sex of these animals was not described and therefore the data are difficult to evaluate thoroughly.

Diabetes Mellitus {#s0070}
-----------------

Diabetes mellitus is a disease of metabolic dysregulation including abnormal glucose metabolism due to derangement of insulin secretion and development of insulin resistance. Diabetes is often accompanied by dyslipidemia (high LDL, VLDL, and chylomicron levels, and a low level of HDL) and elevated risk for the development of atherosclerosis ([@bib89], [@bib94], [@bib146], [@bib147]).

An animal model of pre-diabetic insulin resistance, the fructose-fed Syrian hamster, is employed to investigate mechanisms mediating overproduction of VLDL in the insulin-resistant state. Feeding fructose for 7 days causes hyperinsulinemia and hyperlipidemia in hamsters with absence of overt hyperglycemia ([@bib267]). Fructose feeding for a 2-week period induces significant hypertriglyceridemia and hyperinsulinemia ([@bib266]). Plasma hepatic lipase activity, and hepatocyte hepatic lipase concentration and mRNA levels are increased in these hamsters ([@bib154]). Activation of farnesoid X receptor (FXR) by the addition of chenodeoxycholic acid in high-fructose-diet-fed hamsters reduces plasma triglyceride and cholesterol concentrations, mainly by decreasing de novo lipogenesis and hepatic secretion of triglyceride-rich lipoproteins ([@bib29]). These studies provide evidence that stimulation of FXR could decrease the risk of hyperlipidemia in the diabetic state.

Diabetes can be experimentally induced in hamsters by different approaches, such as dietary modifications or use of chemical agents. Chemical agents such as alloxan or streptozotocin (STZ) are commonly used to induce diabetes in animal models. To induce chronic diabetes in hamsters, STZ is more effective and reliable when compared to alloxan ([@bib206]). STZ depletes nicotinamide adenine dinucleotide (NAD) in pancreatic β-cells leading to necrosis ([@bib14]). Furthermore, type 2 diabetes can be induced by administration of STZ to hamsters on a high-fat diet, resulting in an increase in serum lipid profile, fasting blood glucose, and fasting plasma insulin level ([@bib307]). Another described method to induce type 2 diabetes in hamsters is to inject nicotinamide intraperitoneally 15 minutes before administration of STZ ([@bib81]). Nicotinamide provides partial protection against the beta-cytotoxic effect of STZ resulting in partial (40%) preservation of pancreatic insulin stores ([@bib169]). Dietary modifications alone, such as feeding high-fat (15%) diets containing modest cholesterol (0.12%) to hamsters, induce type 2 diabetes as well as obesity, hyperinsulinemia, hyperleptinemia, hypercholesterolemia, and hypertriglyceridemia ([@bib283]). A combined hyperlipidemia and diabetes hamster model is induced by feeding a fat-rich diet (3% cholesterol and 15% butter fat) and a single IP injection of STZ. These animals exhibit pathobiochemical changes characteristic of both diabetes and hyperlipemia and show an earlier and more severe induction of diabetic and hyperlipidemic changes compared to either STZ or high-fat diet alone ([@bib246]).

Albino-panda-albino (APA) hamsters develop diabetes with nephropathy following STZ injections ([@bib120]). The STZ-induced diabetic APA hamster is a good model of human diabetic nephropathy because progressive renal lesions are a common component of this model. In addition to renal lesions, the diabetic APA hamster also develops coronary lesions and is an excellent model to investigate the etiology and pathogenesis of aortic dissection accompanying diabetes mellitus in humans ([@bib114]).

Hamsters can be utilized to study islet neogenesis, which is the new formation and differentiation of pancreatic islets. This process is induced in Syrian hamsters by wrapping the head of the pancreas with cellophane tape and is efficient in reversing induced diabetes in hamsters ([Figure 34.2](#f0015){ref-type="fig"} ) ([@bib226], [@bib227]). Islet neogenesis-associated protein (INGAP) is involved in the control of islet development and growth ([@bib209]). INGAP is identified in both endocrine and exocrine pancreatic cells of normal hamsters, consistent with findings in humans ([@bib84]). The hamster provides a model to understand the potential therapeutic application of islet neogenesis in the treatment of diabetes in humans.Figure 34.2Displayed is the pancreas and common bile duct. Cellophane (black) is wrapped around the head of the pancreas to induce islet neogenesis.Modified from Rosenberg 1998, with permission from Wiley InterScience.

Atherosclerosis {#s0075}
---------------

Atherosclerosis is a fibroproliferative disease of the arterial intima caused by the retention of modified low-density lipoproteins and by hemodynamic and redox stresses ([@bib104], [@bib103]). Hamsters are a good animal model to investigate cholesterol metabolism and atherosclerosis because they possess similar lipid metabolism to humans ([@bib16], [@bib86]). As in humans, the main plasma cholesterol carrier in hamsters is LDL ([@bib262]). The hamster LDL receptor gene shows strong sequence and structural similarities to the human gene ([@bib30]). Unlike mice and rats, which lack cholesterol ester transfer protein, hamsters exhibit all enzymatic pathways in lipoprotein and bile metabolism that are present in humans ([@bib30]). The low basal rates of bile acid and cholesterol synthesis, coupled with a lack of CYP7A induction by cholesterol, render the hamster much more sensitive than the rat or mouse to the cholesterolemic effects of excess dietary cholesterol ([@bib115]). In contrast to mice and rats, apolipoprotein (apo) B-48 is exclusively of intestinal origin in hamsters and humans and apoB-100 is exclusively of hepatic origin ([@bib12], [@bib72]).

Hamsters develop atherosclerosis in a predictive manner in response to dietary manipulation and the vascular changes accompanying the development of atherosclerotic plaques are similar to those encountered in humans ([@bib181], [@bib247], [@bib294]). Hypercholesterolemic (0.05% cholesterol and 10% coconut oil) diet-induced atherosclerosis in susceptible hamsters is confined initially to the inner curvature of the aortic arch. Atherogenesis in this region is characterized by the infiltration of monocytes, which become lipid-filled foam cells ([@bib139]). Male hamsters on a hyperlipidemic diet (3% cholesterol and 15% butter fat) develop coronary atherosclerotic lesions which are very similar to lesions seen in humans ([@bib244]). Interestingly, hyperglycemia alone in hamsters induces atherosclerotic lesions in the coronary arteries, aortic arch, and aortic valves, implying that the hyperglycemic hamster could provide a model of diabetes-induced atherosclerosis ([@bib245]).

Albino-panda-albino (APA) hamsters (previously described in the diabetes section of this chapter) develop atheromatous lesions in the aortic arches and show signs of hypercholesterolemia and hypertriglyceridemia with an increased LDL fraction and a decreased HDL fraction following injection of STZ ([@bib100], [@bib145], [@bib192]). The deposition of ApoE and advanced glycation end-products in the atheromatous lesions of these hamsters are similar to humans with atherosclerosis ([@bib192], [@bib145]). The APA hamster, therefore, is a good animal model to study both diabetes and atherosclerosis. Since these conditions are often co-morbidities in humans, this model could provide valuable data to understand the pathogenesis of these diseases and test novel treatments.

The Bio F1B hamster is highly susceptible to diet-induced atherosclerosis. This strain develops aortic atherosclerotic lesions even at low (0.05%) dietary cholesterol concentrations ([@bib140]). F1B hamsters on a 20% fish oil diet developed markedly elevated plasma cholesterol and cholesterol ester concentrations compared to wild-type Syrian hamsters ([Figure 34.3](#f0020){ref-type="fig"} ) ([@bib46]). Wild-type Syrian hamsters typically display increases in both LDL and HDL cholesterol in response to an atherogenic diet ([@bib106]). In contrast, F1B hamsters develop highly elevated LDL-cholesterol concentrations without appreciable alterations of HDL-cholesterol ([@bib139]).Figure 34.3Distribution of lipoproteins (by FPLC system) in fasting plasma samples from F1B (A) and Syrian (B) hamsters. The low-density fractions of plasma cholesterol in F1B hamsters on a fish oil diet (--) was significantly higher than the Syrian hamsters on a similar diet. Both groups of hamsters had a comparable lipoprotein profile when fed monounsaturated-fatty-acid-rich (\-\--) and N6:N3 fatty acid ratio of \~5 (...) diets.From Cheema and Cornish, 2007, with permission from BioMed Central.

Ovariectomized hamsters are used to study postmenopausal hypercholesterolemia ([@bib250]). In humans, there is an association between postmenopausal hormone deficiency and the increased risk for cardiovascular disease ([@bib250]). Similar to postmenopausal women, ovariectomized hamsters experience an increase in serum cholesterol and atherosclerosis. This increase occurs even without feeding a high-cholesterol or high-fat diet ([@bib165], [@bib250]).

Hypercholesterolemic hamsters are also a good model of peripheral arterial disease. Angiogenesis in response to femoral artery-induced hindlimb ischemia is reduced in hypercholesterolemic hamsters ([@bib42]). Feeding a cholesterol-rich diet to hamster causes a chronic angiogenic disorder both at the macro- and micro-vascular levels, mimicking the conditions seen in humans with peripheral arterial disease ([@bib42]). This model is also utilized to study the potency of therapeutic gene transfer to overcome revascularization defects in these patients ([@bib42]).

Non-Cancerous Respiratory Diseases {#s0080}
==================================

Syrian hamsters possess characteristics that make them ideal models for studying human non-cancerous respiratory diseases. Specifically, researchers can induce respiratory diseases in hamsters that closely resemble similar human diseases. This section outlines common inducible hamster models for human non-cancerous respiratory disease and describes scientific and medical advances made using these models.

Smoke Inhalation {#s0085}
----------------

The negative effects of cigarette smoking on the cardiovascular and respiratory systems in humans are well known ([@bib4], [@bib79]). Over the past 10 years, an active area of research focuses on the consequences of smoking on the female reproductive tract ([@bib222], [@bib221]). Epidemiological studies demonstrate that women who smoke cigarettes experience increased rates of reproductive problems, including delay to conception, ectopic pregnancies, lower birth weights, and spontaneous abortions ([@bib68], [@bib167]). Syrian hamsters are a prominent rodent used in female reproductive toxicology inhalation studies including mainstream (MS) smoke (active inhalation of a bolus of smoke) and side-stream (SS) smoke (passive inhalation of smoke). Advantages of hamsters in these studies are that they adapt well to smoking machines and they have reproductive tracts that are large enough to allow thorough evaluation ([@bib167]).

To test the effects of smoke inhalation on reproductive parameters, female Syrian hamsters in various stages of estrous or pregnancy are anesthetized, placed in dorsal recumbency, and exposed through a nose cone to smoke released from the burning end of a cigarette (SS smoke) or to a puff of MS smoke with a puffer box ([@bib167]). A machine of equivalent design that pumps fresh air is used for control animals. Exposure to doses of MS and SS smoke equivalent to those in women who smoke actively or passively (second-hand smoke) is ensured by quantifying serum levels of cotinine, a metabolite of nicotine ([@bib68]). The major downfall of this technique is that it exposes females to either MS or SS smoke, but not to both, as would be the case for an active human smoker ([@bib167]). Female hamsters that inhale either MS or SS smoke twice per day for 7 days, starting 1 month prior to mating and ending at day 7 of pregnancy, develop fewer corpus lutea (CL) with accompanying decreases in CL vascularity ([@bib167]). Additional changes in these hamsters include blebbing of ciliated epithelial cells in oviducts, increases in secretory cells of the ampulla, decreases in the ability of the uterus to stretch, and crowding of fetuses. Functionally, the transport of preimplantation embryos through the oviduct is retarded, and oviduct muscle contraction rate is greatly decreased by smoke inhalation ([@bib68]). Transport rate is more significantly retarded in the SS exposure group, suggesting that SS smoke exposure is more detrimental than MS smoke exposure with regard to embryo transport. Inappropriate transport and implantation could explain the increase in ectopic pregnancy in human smokers. Interestingly, when mating is delayed for 1 month following smoke inhalation, all deleterious effects of MS and SS exposure are ablated ([@bib167]). This indicates that the female reproductive tract can quickly recover from the negative effects of smoke inhalation.

COPD and Emphysema {#s0090}
------------------

Chronic obstructive pulmonary disease (COPD) is a chronic, progressive airflow obstruction with concurrent inflammation of the small airways and emphysema of lung parenchyma ([@bib54], [@bib205]). Emphysema contributes to airflow obstruction by reducing the elasticity of the lung, increasing alveolar size, and increasing airway resistance ([@bib54]). COPD is the fourth most common cause of death in the United States, with a prevalence of approximately 16 million ([@bib205]). Animal models yield clues to the pathophysiology and therapeutic approaches for COPD ([@bib205]).

The Syrian hamster is a useful model to study the emphysema component of COPD because hamsters develop severe diffuse emphysema resembling human panacinar emphysema following a single intratracheal dose of porcine pancreatic elastase ([@bib34], [@bib105], [@bib249] ). Elastase is used as an induction agent because it destroys or impairs the formation of elastin, resulting in emphysema ([@bib252]). The elastase induction model reproducibly results in alveolar damage and destruction of alveolar septa resulting in airway enlargement, and causes lung hyper-inflation, all of which are seen in humans with COPD ([@bib34], [@bib105]). Additionally, elastase-treated hamsters do not gain weight at a normal rate, which is analogous to the weight loss seen in humans with emphysema ([@bib249]). Syrian hamsters are also used as a model for emphysema treatment. Intratracheal instillation of hyaluronic acid in hamsters with elastase-induced emphysema reduces emphysema by binding with and protecting elastic fibers from elastase-induced injury, and may be useful in preventing emphysema ([@bib39], [@bib40]).

Emphysema can also be induced in hamsters by feeding diets deficient in copper ([@bib252]). This model requires chronicity (8--10 weeks), thereby resembling the time course of human emphysema development ([@bib252]). Copper deficiency results in the inhibition of lysyl oxidase-mediated elastin cross-linking, causing impaired elastin formation and emphysema ([@bib252]). Also, since superoxide dismutase requires copper, copper deficiency leads to free radical accumulation which can cleave elastin bonds and attract inflammatory cells to the lung exacerbating emphysema.

A popular hypothesis regarding the pathogenesis of emphysema is that an imbalance between proteases and antiproteases plays a major role in disease development ([@bib34]). When compared to Syrian hamsters, rats develop only mild emphysema when given similar doses of elastin. This could be due to a 60% reduction in serum levels of the antiprotease α1-antitrypsin in Syrian hamsters compared to rats, which leads to low elastase inhibitory capacity, thereby predisposing hamsters to elastase-induced emphysema.

Pulmonary Fibrosis {#s0095}
------------------

Interstitial pulmonary fibrosis (IPF) is a debilitating disease characterized by proliferation of lung fibroblasts, collagen accumulation, loss of alveolar space, reduction in lung volume and compliance, and impairment of gas exchange ([@bib90], [@bib91], [@bib149], [@bib290]). These changes cause hypoxemia and, if the fibrosis is severe, pulmonary insufficiency and fatal hypoxemia ([@bib149]). Currently, there are no adequate treatments for IPF and mortality in humans is high ([@bib90], [@bib121], [@bib290]). Bleomycin, a DNA-interactive antineoplastic drug is a known cause of dose-dependent pneumonitis that progresses to IPF in humans ([@bib90], [@bib91], [@bib149], [@bib276]). The prevalence of bleomycin-induced toxicity is reported to be 10%, with many of these cases resulting in death ([@bib149]).

Bleomycin is one of the most commonly used agents to induce IPF because it causes a similar, reproducible condition in the Syrian hamster ([@bib149]). A single intratracheal installation of approximately 5 mg/kg body weight produces pulmonary fibrosis within 7 days ([@bib149]). Importantly, other organs are unaffected by this treatment and the treatment induces biochemical, inflammatory, and histological changes similar to those seen in the lungs of humans with IPF ([@bib90], [@bib276], [@bib290]). The bleomycin model of IPF involves an initial injury to the lung, followed by an influx of inflammatory cells that release cytokines (i.e. IL-1, TNF-α, PDGF, and TGF-β), leading to increased collagen synthesis and deposition ([@bib121]). A drawback of this model is that it produces high mortality in Syrian hamsters ([@bib90], [@bib149]). A refinement is the three-dose bleomycin hamster model where IPF is produced by the intratracheal instillation of three lower doses of bleomycin into the lungs of anesthetized hamsters at weekly intervals ([@bib90], [@bib290]). This model uses repeated insults on the lung to initiate and sustain the fibroproliferative stage of fibrosis, and is the closest model to human IPF because it provides a multi-hit stimulus for lung injury, causing the slow development of IPF ([@bib290]). There is age-selective resistance to bleomycin in young hamsters due to enhanced antioxidant defenses and bleomycin hydrolase activity in neonates ([@bib149]).

After induction, the hamster model can be used to study antifibrotic compounds ([@bib90], [@bib91], [@bib121], [@bib290]). Transforming growth factor-β (TGF-β) plays a central role in the pathophysiology of excessive extracellular matrix (i.e. collagen) production resulting in IPF ([@bib121], [@bib149]). TGF-β mRNA and protein levels are increased in fibrotic hamster lungs; therefore, suppressing its production constitutes a rational therapeutic approach ([@bib121], [@bib149], [@bib290]). Decorin, a proteoglycan component of collagen fibrils, binds and inactivates all isoforms of TGF-β, offering a potential treatment for IPF ([@bib91]). The antifibrotic drug pirfenidone down-regulates the bleomycin-induced overexpression of TGF-β in the lungs, and pirfenidone is now a clinical therapeutic agent for IPF in humans ([@bib11], [@bib27], [@bib121]). Further, a TGF-β antagonist, TGF-β chimeric soluble receptor, causes significant reductions in fibrosis in the hamster model ([@bib290]).

Another area of IPF treatment research focuses on the elimination of reactive oxygen species (ROS) and increasing NAD and ATP needed for the repair of injured pulmonary tissue ([@bib90]). Dietary supplementation with taurine and niacin inhibits lung fibrosis in the bleomycin induced hamster model ([@bib90]). This defense is provided by the ability of taurine to scavenge ROS and the ability of niacin to replenish NAD and ATP levels ([@bib90]).

Cardiovascular {#s0100}
==============

Syrian hamsters exhibit characteristics that make them desirable models for cardiovascular research. Specifically, spontaneous genetic mutations cause diseases that closely resemble human cardiovascular disease. Further, Syrian hamsters display unique anatomical characteristics, most notably a readily evertible cheek pouch, that facilitate cardiovascular studies.

Cardiomyopathy {#s0105}
--------------

Cardiomyopathy is a primary degenerative disease of the myocardium and is characterized as various forms, such as hypertrophic or dilated, based on gross appearance ([@bib233]). Dilated cardiomyopathy (DCM) is characterized by atrial and ventricular dilation with ventricular wall thinning, severe systolic and diastolic left ventricular dysfunction, and heart failure ([@bib119]). DCM is one of the main causes of congestive heart failure in humans, is the leading cause of hospitalization of older patients in the United States, and is hereditary in 25% of affected patients ([@bib119]). Hypertrophic cardiomyopathy (HCM) is characterized by increased ventricular wall thickness, generally involving the interventricular septum, and normal or reduced left ventricular volume ([@bib216], [@bib219]). HCM is the most common, heritable cardiovascular disease in humans, affecting one in 500 people ([@bib35], [@bib219]). Approximately 10% of humans with HCM eventually develop left ventricular dilation and DCM ([@bib119]). The cardiomyopathic Syrian hamster is a naturally occurring, inherited, established animal model for both dilated and hypertrophic cardiomyopathy. In the hamster, both DCM and HCM are caused by a defect in the δ-sarcoglycan gene, a component of the dystrophin complex, which is inherited in an autosomal recessive fashion ([@bib22], [@bib76], [@bib75], [@bib92], [@bib119], [@bib162], [@bib232], [@bib233]). The Syrian hamster model shares many features with human DCM and HCM and is used to study the pathophysiology, prevention, and treatment of cardiomyopathy ([@bib75], [@bib232]).

All cardiomyopathic Syrian hamsters were originally derived from the polymyopathic line 1.50, providing an example of a single mutation causing different types of cardiomyopathy ([@bib92], [@bib233]). Hamster strains Bio 14.6, UM-X7.1, CHF 146, and CHF 147 are characterized by significant hypertrophy of cardiac muscle, while strains 53.58 and Bio TO-2 are characterized by ventricular dilation without hypertrophy ([@bib92], [@bib119]). Some strains, such as the Bio 14.6, exhibit compensatory hypertrophy progressing to left ventricular dilation, thinning and impaired function, while strains such as TO-2 develop dilated cardiomyopathy without an initial hypertrophic response ([@bib92], [@bib119]). These various strains provide diverse models which can be used to study various aspects of pathogenesis.

Many features of the TO-2 dilated cardiomyopathy strain closely resemble those of human DCM so this strain is used commonly to characterize the pathophysiology and hemodynamic profiles of DCM in humans ([@bib76], [@bib92]). TO-2 strain cardiomyopathy is progressive, beginning with myolysis, then developing fibrosis followed by hypertrophy and dilation, and culminating in congestive heart failure ([@bib56], [@bib76]). These stages represent the majority of phases seen in humans with cardiomyopathy, including heart dilation, ventricular hypertrophy, fluid congestion, and death ([@bib56], [@bib76]). Acute myocarditis is also observed in humans and hamsters ([@bib76]). The common hemodynamic features include low cardiac output, elevated left ventricular end-diastolic pressure, delayed left ventricular relaxation rate, increased peripheral resistance, and reduced renal blood flow.

In the TO-2 Syrian hamster, abnormal sarcoplasmic reticulum function results in calcium sequestration and overload, and high ATPase activity results in decreased contractility. These features are partially responsible for decreased cardiac function in this strain, and these abnormalities are hypothesized to be a pathogenic mechanism in human DCM ([@bib92]). Deficiency of the δ-sarcoglycan gene also affects peripheral and coronary vasculature, ultimately contributing to heart failure in cardiomyopathic hamster models ([@bib76], [@bib75], [@bib162]). Angiotensin II promotes increased oxidative stress and decreased peripheral vasorelaxation, leading to high systemic blood pressure and increased cardiac work load in cardiomyopathic prone TO-2 hamsters ([@bib76]). Angiotensin-II-dependent oxidative stress influences coronary vasculature by causing endothelial dysfunction which predisposes hamsters to the development of ischemic heart disease and cardiomyopathy ([@bib75]). Based on the similarities between cardiomyopathic Syrian hamsters and humans, these results associate angiotensin II with the development of cardiomyopathy in humans with hereditary sarcoglycanopathies ([@bib75]).

Current medical treatment for human dilated and hypertrophic cardiomyopathy is only palliative ([@bib233]). Syrian hamster cardiomyopathic strains are used in research targeting prevention and treatment of the condition. The treatment of cardiomyopathic hamsters with angiotensin-converting enzyme (ACE) inhibitors improves left ventricular contractility and coronary flow, providing evidence that Syrian hamsters are useful models in studying drug treatment interventions. Coronary vasculature renin-angiotensin system (RAS) plays a role in generating increased coronary reactivity and resistance in young Syrian hamsters that have yet to develop cardiomyopathy. Early RAS blockade may prevent and improve the clinical signs of cardiomyopathy ([@bib75]). Finally, the administration of carvedilol, a non-selective β-blocker with α~1~-blocker properties, to 6-month-old TO-2 hamsters, improves cardiac function due to decreased peripheral resistance ([@bib56]).

Microcirculation {#s0110}
----------------

The bilateral cheek pouches of the Syrian hamster are invaginations of the oral mucosa which extend to the shoulder region and possess a retractor muscle ([@bib265]). These anatomical structures are highly vascular, thin, easily transilluminated, and can be everted with blood flow intact, making the hamster cheek pouch ideal for intravital microscopy and microcirculation research ([@bib59], [@bib128], [@bib133], [@bib265]). Numerous preparations are described in the literature to observe the hamster cheek pouch microscopically. These methods perfuse the tissue with a bicarbonate-buffered saline solution and maintain physiological temperature, oxygen tension, and pH in an anesthetized hamster ([@bib59], [@bib95], [@bib265], [@bib301]).

With the everted method, the cheek pouch is grasped with forceps, pulled through the mouth, and pinned over a specialized Lucite support pedestal ([@bib59], [@bib204]). Longitudinal and transverse incisions allow exposure of the pouch in a single-layer preparation with high optical clarity, making this method one of the standards for microcirculation studies ([@bib59], [@bib265]). The disadvantages of the everted preparation are restricted blood flow due to tension on the retractor muscle, and the requirement of pouch incisions. Refined everted techniques eliminate the disadvantage of restricted blood flow. Following a skin incision to expose the pouch the retractor muscle is removed and a thin glass support plate is positioned in the cheek pouch which allows unrestricted blood flow. The everted pouch can then be observed in a chamber attached over the microscope condenser system. This preparation decreases surgical trauma and preserves the entire cheek pouch vascular supply ([@bib59]).

An alternative method is the use of a skin incision in the neck followed by ligation and cutting of the retractor muscle at the point of insertion and retraction of the cheek pouch through the skin incision ([@bib301]). This preparation eliminates tension on the retractor muscle, but requires more surgical manipulation than the everted technique.

A third method, the chamber method, involves incising the skin over the cheek pouch, inserting a translucent chamber through the hamster's mouth into two cheek pouch incisions, and illuminating the chamber with a Lucite rod inserted into the mouth ([@bib95]). This method can be used for acute and chronic experimentation, and does not place excessive tension on the retractor muscle. The primary disadvantage of this method is limited transillumination ([@bib59]).

A detailed three-dimensional intravital microscopic view of hamster microcirculation can be visualized using one of the above-described preparations, and intravenous injection of fluorescein-labeled dextran ([@bib73], [@bib265]). Intravital microscopy is also used for observation of the microcirculation of non-anesthetized Syrian hamsters using the dorsal skinfold chamber method ([@bib73], [@bib151], [@bib178], [@bib191]). After implantation of two catheters into the jugular vein and carotid artery, two titanium frames are implanted into the dorsal skinfold to extend the double layer of skin. One layer is completely removed and the remaining layer is covered with a cover slip. This preparation allows for chronic studies of microcirculation ([@bib178]).

Ischemia Reperfusion {#s0115}
--------------------

The hamster cheek pouch is used to study ischemia--reperfusion injury. Ischemia--reperfusion injury is important because it contributes to tissue damage during myocardial and cerebral infarction, and following surgical manipulations that interrupt and then restore blood flow, such as during vascular and organ transplantation and reconstructive surgery ([@bib61], [@bib191]). Ischemia--reperfusion injury is caused by several factors including the generation of reactive oxygen and nitrogen species and the resulting lipid peroxidation; cytokine production following leukocyte margination, adherence, and infiltration; and activation of the complement system ([@bib60], [@bib61], [@bib126], [@bib304] ). The Syrian hamster is extensively used to reveal the pathophysiological mechanisms of ischemia--reperfusion injury, as well as therapeutic options to preserve tissue and vascular viability.

Numerous models of ischemia--reperfusion injury are described using the Syrian hamster cheek pouch. In the model of pressure-induced ischemia a translucent pressure chamber is pressed against the cheek pouch for variable amounts of time and then released to produce reperfusion ([@bib224], [@bib304]). The disadvantage of this model is that the results are influenced by the pressure applied to the tissue. In a second model, ischemia is produced by tightening a latex cuff around the neck of an everted cheek pouch for up to an hour followed by cuff release ([@bib204], [@bib304]). The disadvantage of this model is that tension on the retractor muscle is produced by the everted preparation. Alternatively, ischemia can be induced by compressing the feed arteries and collecting veins of the pouch with a piece of silastic tubing or atraumatic microvascular clips ([@bib25], [@bib61]).

In the incomplete ischemia model, ischemia of the cheek pouch is produced by occluding the ipsilateral common carotid artery, its external branch, and the contralateral external carotid artery ([@bib74], [@bib304]). Partial ischemia better reproduces ischemia as seen in the clinical setting, when compared to models of global ischemia. The disadvantages of this model are that the degree of ischemia is not easily evaluated, and occlusion of the carotid arteries reduces cerebral blood flow ([@bib304]). A further refinement of the incomplete ischemia model is produced by selecting two sections of cheek pouch and placing a triangular chamber made of polyester/plastic film in each area. Ischemia is induced by applying a set amount of pressure to a cover slip over one of the chambers, while the other area acts as a control. Increased pressure is avoided by using a 1.0-mm aperture at one of the chamber corners. Reperfusion is produced when pressure is released after 1 hour ([@bib304]). The advantages of this method include decreased trauma to the pouch microcirculation, the ability to select various sizes of tissue, the maintenance of blood flow in surrounding microvasculature, and the ability to study both ischemic and non-ischemic areas simultaneously. In addition to the cheek pouch, the dorsal skin-fold chamber method can be used in ischemia reperfusion research utilizing an O-shaped silicone ring pressed into the tissue with an adjustable screw clamp, leading to cessation of blood flow into and out of the chamber ([@bib207]).

While Syrian hamster ischemia--reperfusion models are broadly used for elucidating the pathophysiology of the condition, the models are also utilized in the development of prevention and treatment ([@bib25], [@bib207]). Melatonin, a potent antioxidant, effectively preserves microcirculation in the hamster cheek pouch during ischemia reperfusion, making melatonin administration a possible preventative measure during situations when ischemia reperfusion injury is a possibility ([@bib25]). Another possible preventative intervention is daflon, a highly purified flavonoid with anti-inflammatory and antioxidative properties. Daflon blocks immigration and accumulation of leukocytes in perivascular tissue during ischemia reperfusion in the Syrian hamster ([@bib207]).

Infectious Disease Research {#s0120}
===========================

Syrian hamsters were introduced as a laboratory animal species in 1930 due to their susceptibility to *Leishmania* spp*.* and ease of breeding in captivity ([@bib2]). Prior to the use of Syrian hamsters, Chinese hamsters were the only suitable models for *Leishmania* research but they did not breed well in captivity and had to be imported from the Far East ([@bib2]). Early on, Syrian hamsters were also found to be useful models for tuberculosis and brucellosis. Syrian hamsters remain a valuable tool for studying many infectious diseases due to their relative lack of spontaneous diseases compared to other rodent models, and their susceptibility to many experimentally induced infectious diseases ([@bib101]).

Viruses {#s0125}
-------

### Hantavirus {#s0130}

Hantavirus pulmonary syndrome (HPS) is a severe infectious disease caused by numerous members of the *Bunyaviridae* family ([@bib124], [@bib287]). HPS can range from a typical flu-like disease with fever to fatal pneumonia. Unlike other diseases caused by Hantavirus, HPS is transmitted by aerosol and wild rodents in the family *Cric*e*tidae* are the natural hosts of these infectious agents ([@bib113]). Research conducted on HPS agents must be conducted at ABSL-4 facilities.

The hamster serves as an experimental model to study the pathogenesis of HPS. Specifically, the Syrian hamster is highly susceptible to Andes and Maporal viruses which cause fatal pneumonia and edema in experimentally infected hamsters ([@bib173], [@bib180], [@bib287]). In contrast, Sin Nombre virus readily infects the hamster but does not cause disease. Further, Choclo virus is not fatal in the hamster ([@bib78]). These varying results create an understanding of how these agents produce disease. Specifically, Choclo virus damages the endothelium of the lung without significantly inciting inflammation ([@bib78]). In contrast, Andes virus targets endothelium and induces a proinflammatory response ([@bib78], [@bib113], [@bib112]). This same proinflammatory response is noted in humans with severe HPS. It therefore seems likely that more pathogenic viruses produce disease by both directly damaging lung endothelium and inducing a potent proinflammatory response ([@bib78], [@bib113], [@bib112]). Based upon these data a potential treatment of HPS would be the initiation of anti-inflammatory therapy.

### Coronavirus (SARS) {#s0135}

In 2003, an outbreak of a previously unknown condition, severe acute respiratory syndrome (SARS), affected more than 8000 people and resulted in 774 deaths across 30 countries ([@bib238]). The etiological agent of SARS was identified as a novel coronavirus, SARS-CoV ([@bib70]). The outbreak was controlled through quarantine of infected individuals and travel advisories ([@bib261]). The possibility of future SARS outbreaks has led to the search for an appropriate animal model to study the pathogenesis and potential therapeutics for SARS ([@bib261]).

In the hamster model, a high virus titer develops in the respiratory tract following intranasal inoculation of SARS-CoV ([@bib218]). In the lungs, peak viral replication occurs two days post-infection and is cleared by day 7; however, low levels of virus are present in the nasal turbinates for up to 14 days ([@bib218]). SARS-CoV elicits a robust neutralizing antibody response in the hamster which can be detected in sera at day 7 post infection and hamsters are protected from re-challenge by 28 days after initial infection ([@bib218]). In hamsters, viral replication occurs in epithelial cells of the respiratory tract and causes interstitial pneumonia, pulmonary consolidation, and diffuse alveolar damage. A positive correlation exists between pulmonary viral titer and the extent of pneumonia, making the hamster an excellent model for studying the efficacy of potential vaccines and immunotherapy for SARS ([@bib261]). Despite the high level of viral replication and associated histopathological lesions, hamsters exhibit no overt clinical signs ([@bib218]).

Immunotherapy with anti-SARS-CoV monoclonal antibodies (MAbs) has been tested in the hamster model ([@bib217]). In these studies, the virus is administered intranasally and 24 hours post-infection hamsters are treated with MAbs by intraperitoneal injection. Treatment with MAb 201, a SARS-CoV-specific MAb, significantly reduces viral replication and the severity of pulmonary lesions in hamsters ([@bib217]). There is a 1000-fold reduction in viral titer when MAb 201 is given at a dose of 40 mg/kg and a 10 000-fold reduction when given at a dose of 80 mg/kg.

Cyclophosphamide-induced immunosuppression increases the severity of SARS in hamsters when given prior to and during infection ([@bib238]). In these studies, hamsters are first given a loading dose of cyclophosphamide (140 mg/kg) 2--5 days prior to infection, and then a maintenance dose (100 mg/kg) every 3--4 days throughout the course of the study. In treated animals the virus displays a more expansive tissue tropism and high titers are present in the lung, liver, spleen, kidney, and heart and treated animals exhibit weight loss and mortality. This condition is similar to humans with SARS who develop extrapulmonary lesions including splenic atrophy, acute tubular necrosis in the kidneys, neuronal edema and degeneration, heart edema, and myocardial fiber atrophy ([@bib98]). While the immunosuppressed hamster model does not replicate all of the extrapulmonary lesions in humans it more closely mimics the human disease presentation when compared to the immunocompetent hamster model ([@bib238]).

Bacteria {#s0140}
--------

### *Leptospira* spp. {#s0145}

Leptospirosis, caused by organisms in the genus *Leptospira*, is a potentially fatal disease affecting humans and animals worldwide ([@bib99]). In humans, clinical signs range from asymptomatic to high fever, severe headache, chills, muscle aches, vomiting, diarrhea, jaundice, abdominal pain, and a rash ([@bib13]). If the disease is left untreated, kidney damage, meningitis, liver failure, respiratory distress, and death are possible. Leptospirosis is contracted by ingestion or contact with contaminated water, food, or soil ([@bib99]).

Two strains of *Leptospira interrogans* (L1--130, Kito) and three strains of *Leptospira noguchii* (Cascata, Hook, and Bonito) produce an acute lethal infection when inoculated intraperitonally into Syrian hamsters ([@bib243]). Leptospirosis in hamsters is characterized by hepatic and renal complications similar to those seen in acute lethal infection in humans ([@bib243]). Clinical signs that may be observed by the fourth day post-infection include hemorrhage, dehydration, ruffled fur, decreased activity, and isolation from cohorts. Hamsters infected with L1--130 or Kito strains die 7--14 days after inoculation, while hamsters infected with Cascata, Hook, or Bonito die 7--22 days after inoculation. The reproducible lethal nature of these isolates in hamsters, coupled with lesions in target organs that resemble leptospirosis in humans, provides a useful animal model.

Through the use of this model, new treatment and prophylactic modalities can be tested. For example, azithromycin is an effective treatment for acute leptospirosis in hamsters, with 100% survival, following only two doses initiated 2--4 days post infection ([@bib186]). Azithromycin provides an alternative to the standard doxycycline or penicillin treatment because it lacks contraindications in young children and pregnant women ([@bib122], [@bib186]).

### Clostridium difficile {#s0150}

*Clostridium difficile*, a Gram-positive spore-forming bacillus, is the leading cause of antibiotic-associated diarrhea in humans ([@bib210]). Disease occurs when the normal colonic flora is disrupted typically due to clindamycin, ampicillin, or cephalosporin administration and overgrowth of toxin-producing strains of *C*. *difficile* ([@bib210]). Pathogenic strains of *C. difficile* produce two toxins, enterotoxin A and cytotoxin B, which are the major virulence factors for *C. difficile* ([@bib215]). Outbreaks of *C*. *difficile*, beginning in 2000, are attributed to a newly recognized strain, known as the BI strain ([@bib172]). In addition to the other toxins mentioned the BI strain of *C. difficile* produces a binary toxin, has an 18-bp deletion in the *tcd*C locus (a negative regulator of toxin A and B), and is resistant to fluoroquinolone antibiotics ([@bib172]). Patients that acquire *C. difficile* may remain asymptomatic carriers or develop diarrhea, pseudomembranous colitis, or toxic megacolon ([@bib7]). Treatment consists of stopping the initiating antibiotics and beginning treatment with metronidazole or vancomycin for 10 days. Relapse after completion of treatment occurs in about 20% of cases ([@bib202]).

The Syrian hamster model for *C*. *difficile* closely mimics several important aspects of human infection ([@bib135]). Hamsters are orally gavaged with clindamycin followed by gastric inoculation of *C. difficile* 24 hours later ([@bib135]). Hamsters exposed to this experimental paradigm develop hemorrhagic typhlitis, similar to antibiotic-associated pseudomembranous colitis in humans, followed by death within 3 days of infection ([@bib135]). Clinical signs of infection may include diarrhea, weight loss, ataxia, dyspnea, and death ([@bib21]). Highly virulent strains may cause death without any premonitory signs ([@bib215]).

Hamsters, like humans, may succumb to a relapse after completing treatment of the primary disease ([@bib135]). Hamsters receiving vancomycin, the historical treatment for human *C. difficile*-associated colitis, display a 75% recurrence rate by 28 days post-initial-infection ([@bib135]). However, treatment with Rifaximin, a non-absorbable oral antibiotic, results in a 0% recurrence rate, potentially providing refinement to therapy in humans ([@bib135]).

The hamster model of *C*. *difficile* is also used to test the use of human monoclonal antibodies (HuMAbs) directed against either toxin A (CDA1) or toxin B (MDX-1388) ([@bib21]). Intraperitoneal administration of CDA1 and MDX1388 daily for 4 days prior to inoculation with *C. difficile* protects against mortality both in the primary disease and in the relapse model of infection ([@bib21]). The use of HuMAbs may provide a useful therapeutic option either alone or in combination with antibiotics for treatment of humans with *C*. *difficile* colitis ([@bib21]).

### Mycoplasma pneumoniae {#s0155}

*Mycoplasma pneumoniae* is the leading cause of pneumonia in children and young adults ([@bib65]). A majority of the cases result in upper respiratory tract infections, with fever, cough, sore throat, headache, and malaise, but some cases may progress to tracheobronchitis or pneumonia ([@bib65]). Antibiotics may reduce the severity of disease, but do not eliminate the infection ([@bib85]). Recovery from *M. pneumoniae* infection protects the individual from reinfection, suggesting that the development of a vaccine is the most promising approach to controlling *M. pneumoniae* infections ([@bib23]).

Syrian hamsters, which do not harbor *Mycoplasma* spp. as part of their indigenous microbiota, provided an early model for studying *Mycoplamsa* and potential vaccines and therapeutics ([@bib23]). In this model, *M. pneumoniae* is inoculated into hamsters via either the aerosol, intranasal, or intratracheal routes, and infection results in changes that are consistent with natural human disease ([@bib48]). The intratracheal route consistently produces pulmonary disease of greater severity with greater colonization than the other routes of exposure ([@bib23]). In general, peak disease severity occurs 2 weeks post inoculation with hamsters over 6 weeks of age becoming most severely affected ([@bib23]). Assessment of experimental vaccines and other therapeutics can be accomplished by assessment of lung lesion scores. Specifically, lung lesions are scored microscopically by evaluating the degree of leukocyte cell infiltrates, luminal exudate, and parenchymal pneumonia in three cross-sections of the entire lung ([@bib23]). Alternatively, following treatment with a potential chemotherapy agent, viable mycoplasmas in the lung can be quantitated by homogenizing the lungs in mycoplasma liquid medium and plating serial dilutions on agar medium. The use of the hamster in *M. pneumoniae* research has decreased in recent years (2000 and beyond). This reduction likely stems from the wide availability of mice free of *Mycoplasma* spp.

### Treponema pallidum {#s0160}

Two forms of syphilis occur in humans: the venereal form with primary, secondary, and tertiary manifestations and possible congenital transmission, and the endemic form that is usually seen in childhood and is transmitted between children by close contact. In humans, *Treponema pallidum* subsp. *pallidum* is the etiologic agent for venereal syphilis and *T. pallidum* subsp. *endemicum* is the etiologic agent for the endemic form ([@bib125]). In the venereal form, primary lesions present as small painless firm raised sores at the site of contact that heal in 3--6 weeks ([@bib171]). Secondary lesions occur about 2--10 weeks after the primary lesions and are characterized by widespread cutaneous and mucocutaneous lesions with lymphadenopathy that lasts for several weeks ([@bib171]). The tertiary stage occurs in about a third of people that do not receive treatment and appears after a latent period of 5 or more years. Internal organs are the target for the tertiary stage of syphilis, primarily causing cardiovascular or neurologic damage.

When Syrian hamsters are infected with *T. pallidum* subspecies *endemicum*, a disease process similar to human venereal syphilis develops ([@bib125]). Intradermal injection of *T. pallidum* into the inguinal regions of hamsters results in primary lesions at the site of inoculation. The primary lesions form about 3 weeks after inoculation as erythematous papules, which enlarge and become ulcerated by 4 weeks ([Figure 34.4A](#f0025){ref-type="fig"} ). The lesions continue to expand until the sixth to eighth week post-inoculation when they begin to heal slowly ([@bib125]). Around 24 weeks post-infection, secondary lesions develop as perioral ulcers ([Figure 34.4B](#f0025){ref-type="fig"}) and an erythematous rash on the paws and cranial trunk ([@bib125]). Most infected hamsters die within 28--32 weeks following inoculation due to malnutrition from the presence of severe perioral ulcers. If the hamster survives, the perioral ulcers will resolve. Tertiary lesions in hamsters are not documented; however, this could be due to the rarity of survival past the secondary stage.Figure 34.4Hamster with syphilitic lesions. (A) Primary cutaneous lesions form at the site of inoculation as erythematous papules which enlarge and become ulcerated with raised indurated borders. (B) Secondary lesions spontaneously develop approximately 24 weeks after infection in the form of perioral ulceration.From Kajdacsy-Balla et al. 1993 with permission from the American Society for Investigative Pathology.

Gross pathologic features of hamster syphilis include lymphadenopathy and thymic atrophy ([@bib125]). Histologic features include generalized follicular hyperplasia of lymph nodes, hepatic periportal foci of mononuclear cells, and a diffuse increase in mononuclear cells in the sinusoids. The perioral ulcers are characterized by an intense polymorphonuclear infiltrate at their base. Treponemes are visualized in the lymph nodes and perioral ulcers by dark-field microscopy. Persistent latent infection is demonstrated in these animals by transfer of lymph node material into naïve hamsters.

Hamsters infected prior to pregnancy transmit syphilis to their offspring congenitally. A majority of the offspring exhibit rhinitis, about a third develop perianal and perigenital lesions, and a quarter are stillborn or die shortly after birth ([@bib125]). Human congenital syphilis also results in about 25% of prenatal infections resulting in stillbirth, while 25--30% of newborn infants die shortly after birth and 40% develop syphilis later in life ([@bib55]).

Experimental infection of hamsters with *T. pallidum* provides a model to study syphilis infection and drug therapy. Daily clarithromycin given over 7 days successfully eliminates infection in hamsters ([@bib6]). Success is confirmed by failure to infect susceptible hamsters following inoculation with lymph node material from treated hamsters ([@bib6]). These findings may prove useful in establishing alternatives to penicillin treatment, which is the drug of choice for treating human infections.

Hamsters infected with *T. pallidum* for 8 weeks then treated with 4000 IU of penicillin to clear the infection are susceptible to reinfection ([@bib239]). However, hamsters infected with *T. pallidum* for 10--16 weeks and treated with 4000 IU of penicillin are resistant to reinfection ([@bib239]). Following re-inoculation with *T. pallidum*, hamsters do not develop lesions and treponemes are not detectable in the lymph material. The hamster's ability to develop resistance to *T. pallidum* may prove useful in studying human syphilis vaccine development.

While many features of the hamster *T. pallidum* subsp. *endemicum* model make it an excellent model for studying congenital syphilis, it does not utilize *T. pallidum* subsp. *pallidum*, which is the agent that causes congenital syphilis in humans. Hamsters do not develop any lesions in response to *T. pallidum* subsp. *pallidum*. In contrast guinea pigs do develop congenital syphilis in response to *T. pallidum* subsp. *pallidum*, and are therefore more popular current models in the study of congenital syphilis.

Parasites {#s0165}
---------

### Toxoplasma gondii {#s0170}

*Toxoplasma gondii* is an intracellular parasitic protozoan widely distributed in nature. Cats are the definitive host, but all mammals may serve as intermediate hosts. In all hosts, the parasite forms cysts within various tissues ([@bib127]). Approximately 23% of adolescents and adults in the United States have anti-*T. gondii* antibodies ([@bib189]). In some areas of the world, up to 97% of people are positive for *T*. *gondii* antibodies ([@bib235]). Infection is usually asymptomatic; however, infection during pregnancy may lead to abortions or to offspring that develop mental retardation, epilepsy, or toxoplasmic retinochoroiditis ([@bib163]). Ocular disease resolves spontaneously, but reoccurs frequently, and may result in episodic blindness ([@bib201]).

The hamster is a reliable model of toxoplasmic retinochoroiditis. Hamsters inoculated intraperitoneally with cysts of *T*. *gondii* strain ME 49 develop ocular disease without systemic illness ([@bib201]). Retinal lesions develop in both eyes by 2--3 weeks after inoculation and cysts form as white pinpoint to optic disc-sized lesions, primarily at the posterior pole of the inner retina. Four weeks post-infection, the lesions enlarge and develop diffuse indistinct edges with vasculitis and occasionally vitritis. Regression typically occurs by 8--9 weeks, but retinal atrophy may persist ([@bib201]).

Oral administration of *T*. *gondii* ME 49 results in a comparable outcome with no systemic signs of illness, and similar but less severe ocular lesions ([@bib93]). The lesions appear similar in color and position in the retina, however, they are smaller in size, fewer in number, associated with a milder inflammatory reaction, and first appear approximately 1 week later than with the intraperitoneal route.

During the past decade, mice have replaced hamsters as the model of choice for studying ocular toxoplasmosis. Mouse models offer the advantages of a completed genome, the wide availability of knock-out strains, and the ability to reproduce many features of human ocular toxoplasmosis.

### Babesia microti {#s0175}

*Babesia* spp. are protozoal pathogens that infect red blood cells. Many *Babesia* spp. are found in animals, but *Babesia microti* is the main cause of infection in humans and is transmitted by *Ixodes scapularis* ticks ([@bib284]). Babesiosis in humans can range from asymptomatic to life-threatening. Hemolytic anemia and flu-like symptoms are possible, especially in people without a functional spleen or in people that are otherwise immunocompromised ([@bib284]).

Syrian hamsters provide a reliable model of babesiosis through intraperitoneal inoculation with *B. microti*-infected red blood cells ([@bib299]). Without treatment, infection is patent for 3--5 weeks, and hamsters develop severe anemia and marked parasitemia with low mortality. Parasitemia is evident by day 7 post-inoculation, with a peak parasitemia occurring by day 14. This is followed by a carrier state with low or undetectable levels of parasites.

Because Syrian hamsters are highly susceptible to *B. microti* infection they are commonly utilized to maintain *B. microti* within the laboratory. *B. microti*-infected hamster blood can be used to infect other animals or they may be used for in vitro studies of *Babesia* during infection of erythrocytes.

The hamster model also provides a valuable tool for assessing new therapeutic options for human babesiosis. Drug treatments are initiated once parasitemia reaches 3--7% of the total red blood cell population ([@bib168]). To determine whether a treatment elicits a complete cure, blood is drawn from a treated hamster 14 days after the last drug dose and administered by intraperitonal injection into a naïve sentinel hamster. The sentinel hamster is then monitored weekly for 6 weeks for development of parasitemia by examination of thin blood smears ([@bib168]).

Utilizing this experimental approach, clindamycin consistently eradicates *B. microti* in hamsters ([@bib230]). The combination of quinine and clindamycin results in a more significant and faster therapeutic response and is now the treatment of choice for severely ill human patients with babesiosis ([@bib230], [@bib295]). The combination of atovaquone and azithromycin also eliminates *B. microti* in hamsters and is an alternate therapy for human cases of babesiosis that are resistant to clindamycin and quinine ([@bib80], [@bib295]).

### Leishmania donovani {#s0180}

Visceral leishmaniasis is caused by *Leishmania donovani*, an intracellular protozoan transmitted by sandflies ([@bib45]). Visceral leishmaniasis is a progressive disease characterized by prolonged fever, hepatosplenomegaly, anemia, leukopenia, severe weight loss, and ultimately death ([@bib171]). Pentavalent antimonial drugs, such as sodium stibogluconate, are the treatment of choice, despite harmful side effects and significant levels of drug resistance ([@bib263]). Identifying more effective chemotherapeutics is the focus of research for this disease ([@bib300]).

Hamsters can be experimentally infected with *L. donovani* by intracardiac injection under anesthesia or intraperitoneal injection of amastigotes ([@bib62], [@bib300]). Intracardiac injection results in a more rapid infection than the intraperitoneal route; however, the intraperitoneal route results in a greater parasite burden in the spleen ([@bib300]). Systemic *L. donovani* infection results in clinicopathological features that closely mimic the human disease ([@bib175]). Infection of the hamster results in a persistent increase in parasite burden, progressive cachexia, hepatosplenomegaly, pancytopenia, hypergammaglobulinemia, and ultimately death ([@bib175]).

Early detection of infection can be accomplished using a latex agglutination test developed to diagnose visceral leishmaniasis in dogs ([@bib300]). The assay is based on detection of a low-molecular-weight glycoconjugate in the urine. Hamster urine must be diluted 1:10 in phosphate-buffered saline before testing due to its concentrated nature, which creates a vast excess of antigen in the test sample that can result in false-negative results.

Weight loss is the most commonly used ante-mortem indicator of infection in live hamsters ([@bib300]). Early detection of infection can be accomplished by comparing body weights between inoculated and control juvenile hamsters where control hamsters gain weight significantly faster than age-matched infected hamsters ([@bib300]). Weight loss of 25% is used as the end-point for tissue collection and post-mortem analysis and parasite burden can be purified and quantified from a homogenate of the spleen at this endpoint ([@bib62]).

### Trypanosoma cruzi {#s0185}

Chagas disease is caused by the flagellate protozoan *Trypanosoma cruzi* ([@bib132]). In Chagas-endemic areas of Central and South America, the most common route of infection is from the triatomine insect, which shed *T. cruzi* in their feces. Chagas disease is comprised of two phases, acute and chronic. The acute phase lasts for the first few weeks or months following infection and symptoms include fever, fatigue, body aches, headache, rash, anorexia, diarrhea, and vomiting ([@bib132]). Gross lesions may include splenomegaly, hepatomegaly, lymphadenopathy, and local swelling at the site of parasite entry. Rarely, young children or immunocompromised people develop fatal myocarditis or meningoencephalitis ([@bib132]). During the chronic phase, infection may remain dormant for decades; however, up to 30% of infected people will develop life-threatening inflammatory cardiomyopathy 15--30 years following infection ([@bib134]).

Syrian hamsters, following intraperitoneal injection of *T. cruzi*, develop a *T. cruzi*-induced cardiomyopathy resembling human Chagas cardiomyopathy, and display high levels of anti-*T. cruzi* IgG antibodies ([@bib28]). *T. cruzi* infection results in the death of some hamsters during the acute phase, within the first 4 months of infection, and during the chronic phase, after 8 months of infection ([@bib28]). All infected animals develop myocarditis, interstitial fibrosis, and mild-to-severe left ventricular dysfunction ([@bib28]). In the chronic phase, hamsters also develop ventricular dilation and a decrease in ventricle wall thickness ([@bib28]). Hamsters do not develop apical or segmental wall hypocontractility, which are additional features of human Chagas cardiomyopathy ([@bib28]).

The Chagas disease hamster model allows quantitative evaluation of left ventricular function and myocardial lesions throughout progression of the disease. Novel therapeutics and their effect on the progression of cardiac disease can therefore be evaluated rapidly using the acute and chronic hamster model ([@bib28]).

### Opisthorchis viverrini {#s0190}

Epidemiological studies reveal a high prevalence of cholangiocarcinoma in northeast Thailand ([@bib257]). In this region, the traditional diet exposes the local population to infection with the liver fluke *Opisthorchis viverrini* and nitrosamines through consumption of contaminated water and salt-fermented fish ([@bib198]). The use of a Syrian hamster model established a connection between *O*. *viverrini* infection, consumption of nitrosamine, and the development of cholangiocarcinoma ([@bib198]).

Syrian hamsters can be readily infected with *O. viverrini* by oral administration of metacercariae. Infection results in inflammation and fibrosis in the periductular region of the liver, similar to human infection ([@bib44], [@bib198]). Feeding *O*. *viverrini-*infected hamsters subcarcinogenic doses of dimethylnitrosamine results in the development of cholangiocarcinomas in up to 93% of hamsters ([@bib270]). In contrast, administration of subcarcinogenic doses of dimethylnitrosamine alone or infection with *O*. *viverrini* alone does not cause cancer in this animal model, suggesting that these factors interact to produce cholangiocarcinoma ([@bib270], [@bib272]).

After experimental infection with *O. viverrini*, liver procollagen prolyl hydroxylase activity increases, reflecting increased collagen synthesis that is proportional to the intensity of liver fluke infection ([@bib118]). Liver fluke infestation likely acts as an epigenetic promotor of tumor formation, rather than a frank genomic mutagen, by inducing inflammatory and fibrotic changes in the liver ([@bib198]). This is supported by similar studies that utilize complete bile duct ligation in hamsters which results in biliary inflammation and proliferation. If this procedure is performed in hamsters treated with subcarcinogenic doses of dimethylnitrosamine, promotion of cholangiocellular lesions develop similar to the findings in *O. viverrini* infection ([@bib271]).

### *Taenia* spp. {#s0195}

Humans are the natural definitive host for *Taenia solium* and *Taenia saginata* ([@bib17]). Human taeniosis is acquired by ingestion of cysticerci in raw or undercooked pork or beef. In the human small intestine, the cysticerci attach to the intestinal wall and develop into adult tapeworms which become gravid approximately 4 months after infection ([@bib17], [@bib171]). Taeniosis is usually asymptomatic but may result in mild gastrointestinal disturbances ([@bib171]). In contrast, when humans ingest embryonated eggs through ingestion of food or water contaminated with human feces, they may serve as intermediate hosts (cysticercosis) ([@bib171]). The larvae hatch, penetrate the intestinal wall and disseminate to other organs where they encyst ([@bib171]). Cysticerci develop in the central nervous system, heart, eyes, subcutaneous tissue, and skeletal muscle. Clinical manifestations depend on where the cysticerci develop and may include neurologic, cardiac, or ocular deficits, or even death ([@bib17], [@bib18]).

Hamsters can successfully become infected with adult *Taenia* spp. by being fed cysticerci encysted in rodent muscle ([@bib289]). Oral gavage of cysticerci without muscle encasement results in digestion of the cysticerci and no colonization with adult tapeworms ([@bib289]). Tapeworms grow better in hamsters that are immunosuppressed with steroids; however, it is unclear if this is due to a direct effect of the steroids on the tapeworm or due to depression of the host immune response (Avila, 2006). Tapeworms reach lengths in excess of 30 cm after 30 days, but do not form gravid proglottids in the hamster model ([@bib9]).

Utilizing the hamster model, an ELISA, which detects a *Taenia* spp.-specific fecal antigen, was developed and standardized ([@bib8]). In contrast to identification of eggs in the feces, this test can be used to diagnose infection even during the prepatent period. Additionally, the hamster model can be used to study the morphological and ultrastructural attachment of adult tapeworms to the intestinal wall, the results of which may contribute to a better understanding of the biology of tapeworm infections ([@bib179]).

### Ancylostoma ceylanicum {#s0200}

Hookworm infection affects hundreds of millions of people living in tropical and subtropical climates around the world. Adult hookworms attach to the intestinal mucosa and feed on blood from lacerated capillaries. Chronic hemorrhage from the site of attachment leads to iron-deficiency anemia, serum protein loss, and intestinal inflammation ([@bib107]).

Unlike mice, Syrian hamsters are fully permissive hosts for the development of adult *Ancylostoma ceylanicum* hookworms ([@bib38], [@bib43]). Hamsters can be inoculated with infective *A. ceylanicum* third-stage larvae via oral gavage ([@bib177]). Hookworm eggs can be detected in the feces 14 days following infection and live adult hookworms can be recovered from the small intestine and colon ([@bib177]). Infected hamsters experience anemia, weight loss, growth delay, and chronicity of infection, just like children that are infected with hookworms, making them an excellent model for the study of human hookworm infection ([@bib107], [@bib177]).

Hamsters can also be orally inoculated with adult *A. ceylanicum* ([@bib38]). This method allows for the specific study of host responses to bloodfeeding adult hookworms without the confounding influence of prior larval exposure. This model provides the added benefits of allowing for manipulation of adult hookworms by immunologic, genetic, or pharmacologic methods prior to inoculation into the hamsters and for the study of single-sex infections.

### *Schistosoma* spp. {#s0205}

Schistosomiasis is one of the most prevalent parasitic diseases affecting humans in tropical and subtropical climates, with an estimated 779 million people at risk and over 200 million infected ([@bib260]). Following percuntaneous invasion flukes mature and lay eggs within hepatic or pelvic blood vessels and eggs migrate to the liver, intestine, or bladder, causing inflammation and scarring possibly leading to hepatic cirrhosis.

Syrian hamsters can be readily infected with *Schistosoma* spp. cercariae via percutaneous or subcutaneous inoculation ([@bib36]). Chemotherapeutic agents can be tested for effectiveness against the juvenile stage of infection by administration at 21 days post inoculation and against adult worms by administration at 49 days post inoculation.

Prion Diseases {#s0210}
--------------

Transmissible spongiform encephalopathies (TSE), such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy in cattle, or scrapie in sheep are fatal neurodegenerative diseases of the central nervous system ([@bib141], [@bib142]). A common feature of TSE is that normal host cellular prion protein (PrP^c^), which is strongly expressed by cells of the nervous and lymphoreticular systems, converts into an abnormal disease-specific prion protein (e.g. PrP^Sc^ in scrapie) ([@bib142]). This abnormal prion protein is a biochemical marker for TSE and is linked with infectivity.

TSE can be transmitted by oral, intracerebral, intravenous, intraperitoneal, and subcutaneous routes, but the most common route is through ingestion ([@bib142]). To study the course of disease following the oral route of infection, hamsters can be infected with scrapie by housing them with other hamsters that were intracerebrally inoculated with scrapie prions as weanlings ([@bib212]). The experimental hamsters cannibalize the infected hamsters when they become terminally ill. Approximately 120 days after consuming scrapie-infected brain, progressive neurologic signs including ataxia, tremors, and head bobbing develop, and death occurs about 20 days later ([@bib212]).

Injection of scrapie-infected brain homogenate into the foot pad using a 27-gauge needle provides an alternative route of experimental infection ([@bib142]). Clinical signs, starting with muscle tremors, begin approximately 78 days following unilateral foot pad injection ([@bib142]). This method of inoculation provides a shorter incubation time than oral inoculation and allows the distribution of scrapie prion protein in nerve tissue to be assessed at various time points. Utilizing this method, scrapie prion protein is detected in the ipsilateral sciatic nerve 60 days post infection and 80 days post infection in the contralateral nerve ([@bib142]). Within the brain, the red nucleus correlating with the ipsilateral sciatic nerve produces stronger prion protein immunoreactivity compared to the contralateral nucleus. These findings suggest centripetal propagation to the CNS and subsequent centrifugal spread to other nerve projections ([@bib142]).

The role of the lymphoreticular system on the pathogenesis of TSE is also studied using the unilateral foot-pad infection model ([@bib141]). Scrapie prion protein is consistently detected in the ipsilateral popliteal lymph node as early as 2 days post-inoculation. In contrast, the contralateral popliteal lymph node remains negative throughout the study, indicating that systemic spread of scrapie prion protein through the lymphoreticular system does not occur ([@bib141]). Removal of the ipsilateral popliteal lymph node 4 weeks prior to infection with scrapie does not affect the incubation period or mean survival time at high or medium doses; however, at low doses, hamsters remain free of clinical symptoms for 314 days post inoculation (duration of experiment) ([@bib141]). These data suggest that very low doses of scrapie may require replication in the lymphoreticular system prior to invasion of the nervous system ([@bib141]).

Other Models {#s0215}
============

Amyloidosis {#s0220}
-----------

Amyloidosis is an abnormal deposition of highly ordered proteinaceous material in various organ systems of humans and animals ([@bib49]). There are currently 20 clinical syndromes in humans associated with amyloid deposition and each syndrome is classified into primary or secondary amyloidosis based on chemical composition ([@bib117]). Primary amyloidosis is the result of overproduction of immunoglobulin light chains and is principally of neoplastic or genetic origin. Reactive or secondary amyloidosis is the result of the accumulation of β-pleated fibrils composed of serum amyloid A (SAA), an acute-phase protein associated with inflammation ([@bib117]). In addition to SAA, in reactive amyloidosis, amyloid deposits contain a minor protein component called amyloid P (AP) derived from serum AP (SAP) ([@bib49]). Amyloidosis occurs both spontaneously and after induction with amyloid-inducing substances in Syrian hamsters. The spontaneous disease is more prevalent in females compared to males and spontaneous occurrence is promoted by fight wounds, stress, high-protein diets, and various infectious agents ([@bib97]). Syrian hamsters are commonly used as a model of induced amyloidosis, using casein or lipopolysaccharide (LPS) subcutaneous injections ([@bib109], [@bib190]). The lag or pre-amyloid phase associated with these amyloid-inducing substances can be accelerated by intraperitoneal or subcutaneous injection with amyloid-enhancing factors (AEF), which are small fragments of amyloid fibrils ([@bib109], [@bib190]). AEF injection shortens the pre-amyloid phase for splenic, hepatic, and renal amyloid deposition ([@bib109]).

Syrian hamsters are unique when compared to other animal models of secondary amyloidosis because they have an SAP homolog called female protein (FP) which is under estrogenic control ([@bib49]). The hamster amyloid model provides the unique opportunity to hormonally manipulate the synthesis of FP and study concurrent amyloid deposition. Female hamsters, when compared to males, possess higher serum concentrations of FP, acquire more amyloid at an earlier age and die at an earlier age due to amyloid accumulation ([@bib49]). In the Syrian hamster, FP rather than amyloid fibril, plays a predominant role in the sex-limited expression of amyloidosis ([@bib49]). Male Syrian hamsters that are deprived of testosterone by castration or administered diethylstilbestrol (DES) acquire amyloid deposition at an earlier age similar to female hamsters ([@bib49]). The amyloidogenic effect of DES in male hamsters is inhibited by testosterone injections, and female hamsters given testosterone are also protected from amyloid deposition ([@bib49]). These studies established the importance of FP in this disease and it is hypothesized that FP undergoes calcium-dependent binding of amyloid fibrils which stabilizes and protects the amyloid fibrils after formation ([@bib49]).

Sex Behavior and Steroids {#s0225}
-------------------------

Sexual behavior of male humans and most other male mammals is dependent upon gonadal androgen secretion ([@bib174]). Using a hamster model, Schulz and colleagues described the two-stage model of sexual behavior development ([@bib241]). The first stage is the perinatal period when neural circuits become sexually differentiated and the initial programming of adult responses to hormones occurs. The second stage is adolescence, when the structural and functional organization of behavioral circuits are refined and completed, resulting in the expression of sex-typical social behaviors. The presence of testosterone during adolescence results in adults who more readily display male-typical social behaviors compared to adults that matured in the absence of testosterone ([@bib241]). The testosterone exposure during adolescence defeminizes the brain and behavioral responses to estradiol and progesterone ([@bib241]).

Castrated male Syrian hamsters that are treated daily with 1000 µg of dihydrotestosterone (DHT) do not display copulatory behavior or interest in female hamsters in estrus ([@bib15]). In contrast, castrated males treated with 50 µg of estradiol (E2) show sexual motivation but do not display the ejaculation reflex ([@bib15]). Combined treatment with DHT and E2 restores all components of male sexual behavior in castrated males ([@bib15]). Castrated male Syrian hamsters that receive brief infrequent elevations of testosterone display male sexual behavior ([@bib208]). This provides a useful model to assess the neuroendocrine basis of male sexual behavior and raises the possibility that infrequent low-dose androgen replacement may restore sexual behavior in hypogonadal men without inducing negative side-effects.

Flank marking, like reproductive behavior, is activated by testosterone in adulthood ([@bib5], [@bib123]). In contrast, attack behavior toward another male in a resident--intruder paradigm is significantly higher prior to puberty when compared to adulthood, indicating that attack behavior is not under the influence of physiologic testosterone ([@bib225]). Therefore, exposure to gonadal hormones during adolescence and adulthood facilitates aggression towards an intruder and flank-marking behavior, respectively ([@bib225]).

Anabolic steroids are abused by humans for their tissue-building potency and performance-enhancing effects. These steroids induce a variety of negative effects including heightened aggression, changes in sexual libido, testicular atrophy, baldness, cancer, and cardiovascular disease ([@bib152]). Hamsters are used to study the deleterious behavioral effects of exogenous steroid administration. Specifically adolescent (post-pubertal) male hamsters exposed to anabolic steroids for 2--4 weeks show an increase in aggression ([@bib64], [@bib96], [@bib176] ). In addition, when adolescent hamsters are given exogenous anabolic steroids they do not express submissive behaviors such as defensive posturing, escape dashes, or tail-up walking ([@bib234]). Both adolescent male and adult male hamsters treated with anabolic steroids display increased flank marking. In adolescent hamsters, exposure to anabolic steroids results in levels of sexual behavior comparable to adult hamsters. In contrast, steroid administration in adult hamsters results in decreased sexual behavior compared to untreated controls. These studies suggest that the adolescent brain is more vulnerable than the adult brain to the adverse behavioral consequences of exogenous steroids ([@bib64], [@bib96], [@bib176], [@bib234]).

The addiction potential of anabolic steroids is evaluated using a classical self-administration paradigm of drug abuse ([@bib166], [@bib199]). Castrated male hamsters that are supplemented with testosterone self-administer additional testosterone at all doses tested ([@bib69]). In contrast, when testosterone is not exogenously administered, castrated males do not self-administer testosterone ([@bib69]). These findings indicate that circulating androgens enhance the desire to self-administer testosterone. This study also provides strong evidence that exogenous testosterone administration, particularly in individuals that possess endogenous testosterone, poses a strong potential for addiction.

Nutritional Infertility {#s0230}
-----------------------

Limited food availability diminishes fertility in mammals, particularly in females ([@bib37]). The hamster provides a model to evaluate the deleterious effects of inadequate nutrition on fertility. A negative energy balance in hamsters suppresses ovulatory cycles and estrus behavior ([@bib286]). Food deprivation decreases estrogen receptor immunoreactivity in the ventromedial hypothalamus, implying a direct neurological effect of food deprivation in sexual behavior. Treatment with leptin promotes female sexual behavior in ad libitum-fed hamsters; however, in food-deprived hamsters, leptin treatment fails to overcome the loss of estrus behavior associated with poor nutrition. Interestingly, leptin-induced changes in female sexual behavior are not accompanied by changes in estrogen receptor immunoreactivity of the hypothalamus, implying that leptin acts via another mechanism ([@bib285]). Neuropeptide Y (NPY) may play a role in nutritional infertility. Injections of NPY into the central nervous system stimulate robust and long-lasting increases in food intake in hamsters while simultaneously reducing estrus behavior ([@bib53], [@bib144]). These studies provide strong evidence that multiple pathways (leptin and NPY) control alterations in female nutrition-associated fertility.

Generalized Dystonia {#s0235}
--------------------

Dystonia, characterized by involuntary twisting movements and abnormal postures caused by co-contractions of antagonistic muscle groups, is the third most common movement disorder in humans ([@bib214]). The disease is a heterogeneous disorder because patients display clinical signs associated with many different brain regions. Primary dystonia is inherited or arises spontaneously, and secondary dystonia follows brain trauma or insult. These disorders can be further classified, based on affected muscle groups, as focal (involving a small number of muscles) or generalized dystonia (involving all of the muscles throughout the body). The dt^sz^ disorder exhibited in the Bio 86.93 inbred line of Syrian hamsters is an animal model of generalized dystonia ([@bib164], [@bib214]). The disorder in hamsters, originally designated *sz* because of the seizure-like presentation, is inherited in an autosomal recessive fashion ([@bib164]). The mutation was later renamed dystonic and symbolized as dt^sz^. In hamsters, dystonic attacks last several hours, vary in severity, progress from the head to the extremities, and are partially age-dependent with signs mostly disappearing after 8 weeks of age ([@bib214]). The dt^sz^ phenotype is modified by hormonal fluctuations and late-term pregnant and nursing dt^sz^ hamsters experience attacks ([@bib214]). Attacks begin with rapid vibrissae twitching, flattening of the ears, and facial contortions, followed by stiffening of the hindlimbs, gait abnormalities, and falling episodes, ending with limb hyperextension, severe truncal torsion, and immobility ([@bib164], [@bib214]). The dystonic attacks are stress-induced and initiated by placing the hamsters in a new environment. The motor disturbances can also be pharmacologically initiated with subconvulsant doses of pentylenetetrazol (PTZ), picrotoxin, or inverse benzodiazepine receptor agonists ([@bib88], [@bib164]). The generalized syndrome in humans shares many phenotypic features with hamster dystonia including prolonged attacks lasting up to 4 hours, onset in infancy or childhood, and attacks initiated by stress or excitement ([@bib164]).

Wound Healing {#s0240}
-------------

Traumatic damage to tissue is followed by a complex cascade of tissue-repair events that involve overlapping inflammatory, proliferative, and remodeling phases. Research into understanding the process of tissue repair focuses on the role of epithelial cells, fibroblasts, endothelial cells, and inflammatory cells ([@bib296]).

Hamsters provide an excellent model for elucidating the role of eosinophils in wound healing ([@bib296]). The induced model involves creating a circular transdermal wound between the shoulder blades and leaving the wound open to heal by secondary intention ([@bib296]). In normal hamster skin, eosinophils are rarely found; however, a prominent eosinophilic infiltrate occurs during cutaneous wound healing. The eosinophils, and other inflammatory cells, provide a cellular source of two cytokines, transforming growth factor-α (TGF-α) and TGF-β~1~, both important regulators of wound healing.

These two cytokines are expressed from eosinophils in a temporal fashion. Eosinophil expression of TGF-α peaks 5 days after cutaneous injury ([@bib296]) followed by a gradual decline. In contrast, expression of TGF-β~1~ gradually increases throughout wound healing. The early expression of TGF-α is implicated in epithelial migration, proliferation, and angiogenesis ([@bib24], [@bib240]). Later expression of TGF-β~1~ is believed to contribute to the down-regulation of epithelial migration and proliferation, as well as to granulation tissue formation ([@bib213]).

[@bib302] developed an eosinophil-deficient hamster model by treating with anti-interleukin-5 monoclonal antibody (TRFK-5), which inhibits the IL-5-dependent pathway of eosinophil differentiation and maturation. TRFK-5 is injected intraperitoneally 7 and 4 days before and on the same day as wound creation. An absence of eosinophils results in accelerated re-epithelialization of cutaneous wounds, with wound closure occurring 4 days faster than in non-TRFK-5-treated animals. One mechanism which could explain the accelerated wound healing is a reduction in TGF-β~1~, which is antiproliferative for keratinocytes. Eosinophil depletion may be clinically relevant for the treatment of wounds to accelerate wound closure.

Due to the hamster's relatively large oral cavity, an 8-mm circular wound can be created in the oral mucosa overlying the masseter muscle and allowed to heal by secondary intention, providing an excellent model for comparing oral and cutaneous wounds. Similar to cutaneous wounds, eosinophils infiltrate oral wounds and express TGF-β~1~, however, they do not express TGF-α ([@bib303]). The lack of TGF-α expression by eosinophils in oral wounds may reflect the presence of TGF-α and epidermal growth factor (EGF) in hamster saliva. Oral eosinophils can be induced to express TGF-α by first performing sialoadenectomy of the submaxillary and sublingual complex to knock-out the salivary-associated TGF-α and epidermal growth factor (EGF) ([@bib303]). Furthermore, oral eosinophils cease producing TGF-α when EGF is supplemented in the drinking water. This suggests that EGF and TGF-α in the saliva are responsible for the decreased production of eosinophil-associated TGF-α in oral wounds.

NSAID Gastropathy {#s0245}
-----------------

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most frequently used group of drugs in medicine ([@bib229]). Although these drugs are extensively utilized, they may result in significant gastrointestinal injury ([@bib269]). The ability of NSAIDs to inhibit prostaglandin synthesis leads to anti-inflammatory and pain reduction, but also compromises the protective properties of the gastric mucosa, potentially leading to gastric mucosal erosions and ulcers ([@bib228]).

The hamster model of NSAID-induced gastric ulceration is created by subcutaneously injecting indometacin into hamsters ([@bib136]). Indometacin produces gastric antral ulcers in hamsters within 1--5 hours post-administration in a dose-dependent fashion. With repeated administration of indometacin, the gastric lesions become more severe and most hamsters die with perforated antral ulcers after 2--5 days. Indometacin reduces the antral mucosa production of prostaglandin E2, prostaglandin F~2α~, and 6-keto prostaglandin F~1α~ and increases gastric acid output more than twofold. The ulcers created in this model may be prevented by antisecretory agents such as cimetidine, methscopolamine bromide, and omeprazole ([@bib136]).

To create a chronic NSAID-induced gastropathy model in hamsters which more closely mimics the disease process in humans, naproxen can be administered twice daily by oral gavage ([@bib83]). Gastric ulceration occurs almost exclusively in the antrum and increases in size as a function of dose and time for the first 3 days of naproxen treatment. At a dose of 80 mg/kg given twice a day, naproxen can be used for chronic anti-ulcer drug studies with a low (\<5%) mortality rate ([@bib83]). Gastric ulcer area decreases in naproxen-treated hamsters by the fourth day of administration, suggesting adaptation of the gastric mucosa. The process of adaptation involves stimulation of gastric mucosal healing and the creation of a gastric mucosa that is more resistant to future injurious agents ([@bib153]).

The naproxen-induced model provides a useful system to study anti-ulcer drugs. Misoprostol, a prostaglandin analog, when administered in conjunction with naproxen, results in a significant reduction in number and size of gastric ulcers without modifying gastric acid secretion ([@bib83]). This same protection is noted in humans ([@bib57]). Famotidine, an H~2~-receptor antagonist that inhibits stomach acid production, does not reduce the prevalence or number of gastric ulcers in the hamster ([@bib83]). Similarly, H~2~-receptor antagonists do not consistently reduce NSAID-induced gastric ulceration in humans ([@bib57]). These results suggest that gastric acid secretion is not the primary mechanism of naproxen-induced ulceration in hamsters or humans and that the naproxen hamster model accurately models NSAID-induced antral ulceration in humans ([@bib83]).

Gastric ulcer models have also been developed in rats and rabbits using subcutaneous administration of indometacin. Limitations of the rat model include the addition of profound intestinal ulceration and high mortality ([@bib237]). The rabbit antral ulcer model displays ulcers that are morphologically similar to human ulcers without the high mortality or intestinal injury noted in rats (Wallace and McKnight, 1993); however, the relatively large size of rabbits may make them less desireable when compared to hamsters.

Human Fertility {#s0250}
---------------

The hamster zona-free oocyte penetration assay is used to examine human male fertility ([@bib3]). This assay was first described in 1980 and involves the incubation of human sperm with hamster eggs that have undergone zona removal ([@bib197]). The assay can be utilized both clinically and experimentally to determine human sperm fertility and it analyzes the ability of sperm to capacitate eggs, udergo the acrosome reaction, and fuse with the oocyte. Limitations of the assay are that it is labor-intensive, and difficult to standardize. Despite these limitations, results obtained in the hamster assay correlate well with human in vitro fertilization. Since intracytoplasmic sperm injection (ICSI) is replacing standard IVF in many settings the utility of the zona-free hamster assay from a clinical perspective may be waning.
